«A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma»

ΕΝΕΡΓΟ RECRUITMENT Έναρξη Μελέτης: Οκτ-24 Λήξη Μελέτης: 30/1/2030